false
0000888491
0000888491
2023-12-04
2023-12-04
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
December 4, 2023
OMEGA HEALTHCARE INVESTORS, INC.
(Exact name of registrant as specified in
its charter)
| Maryland |
1-11316 |
38-3041398 |
(State or other jurisdiction of
incorporation) |
(Commission File Number) |
(IRS Employer
Identification No.) |
303 International Circle,
Suite 200
Hunt Valley, Maryland 21030
(Address of principal executive offices
/ Zip Code)
(410) 427-1700
(Registrant’s telephone number, including
area code)
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| |
¨ |
Written communications pursuant to Rule 425 under the Securities Act. |
| |
¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act. |
| |
¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act. |
| |
¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act. |
Securities registered pursuant to Section
12(b) of the Securities Exchange Act of 1934:
| Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered |
| Common Stock, $.10 par value |
OHI |
New York Stock Exchange |
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2
of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ¨
If an emerging growth company, indicate
by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Item
7.01 Regulation FD Disclosure.
On December 4, 2023,
Omega Healthcare Investors, Inc. (“Omega” or the “Company”) issued a press release announcing that it had posted
to its website, www.omegehealthcare.com, under the Investor Relations section and under the News & Events section, an updated
investor presentation which includes a revised Operator Updates slide on page 10 of the presentation. The updated investor presentation
is titled “December 2023 Investor Presentation.” The presentation will remain on the Company’s website for a period
of at least thirty days. Omega’s press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.
The information set forth
herein and in Exhibit 99.1 is furnished pursuant to Item 7.01–Regulation FD Disclosure and shall not be deemed “filed”
for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of such section
nor shall the information be deemed incorporated by reference in any filing of the Company.
Item
9.01 Financial Statements and Exhibits.
[The balance of this
page is intentionally left blank.]
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
| |
OMEGA HEALTHCARE INVESTORS, INC. |
|
| |
|
|
|
| Dated: December 4, 2023 |
By: |
/s/ Gail D. Makode |
|
| |
|
Gail D. Makode |
|
| |
|
Chief Legal Officer, General Counsel |
